2009 Annual Report and Notice

RNS Number : 2571J
Hutchison China Meditech Limited
29 March 2010
 



 

 

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

 

2009 Annual Report and

Notice of Annual General Meeting

 

 

London: Monday, 29 March 2010: Chi-Med today announces that its 2009 Annual Report together with the Notice of Annual General Meeting and the Proxy Form have been posted to shareholders.  The documents can be accessed from the website of Chi-Med (www.chi-med.com).

 

 

Ends

 

 

Enquiries

 

Chi-Med

Christian Hogg, CEO

Telephone: +852 2121 8200



Citigate Dewe Rogerson

Anthony Carlisle

David Dible

Telephone: +44 (0) 20 7638 9571

+44 (0) 7973 611 888

+44 (0) 7967 566 919



Lazard & Co., Ltd.

Paul Gismondi

Nick Fowler

Telephone: +44 (0) 20 7187 2000

 

 


About Chi-Med

 

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals and health oriented consumer products.

 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBBGDXGSDBGGL
UK 100